Medical Technology

@xconomy.com 3 years ago

AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact

@xconomy.com 3 years ago

Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact

@xconomy.com 3 years ago

HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic

@xconomy.com 4 years ago

Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug

@xconomy.com 4 years ago

UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma

@xconomy.com 4 years ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@xconomy.com 4 years ago

Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds

@xconomy.com 4 years ago

Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D

@xconomy.com 5 years ago

CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M

@xconomy.com 5 years ago

Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M

@xconomy.com 5 years ago

With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines